Antibiotice Statistics

Total Valuation

Antibiotice has a market cap or net worth of RON 1.21 billion. The enterprise value is 1.35 billion.

Market Cap	1.21B
Enterprise Value	1.35B

Important Dates

The last earnings date was Thursday, April 10, 2025.

Earnings Date	Apr 10, 2025
Ex-Dividend Date	Sep 25, 2025

Share Statistics

Antibiotice has 671.34 million shares outstanding.

Current Share Class	671.34M
Shares Outstanding	671.34M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	1.04%
Float	117.94M

Valuation Ratios

The trailing PE ratio is 11.82.

PE Ratio	11.82
Forward PE	n/a
PS Ratio	1.75
PB Ratio	1.35
P/TBV Ratio	1.38
P/FCF Ratio	n/a
P/OCF Ratio	12.70
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.86, with an EV/FCF ratio of -371.90.

EV / Earnings	13.20
EV / Sales	1.96
EV / EBITDA	8.86
EV / EBIT	12.59
EV / FCF	-371.90

Financial Position

The company has a current ratio of 2.02, with a Debt / Equity ratio of 0.16.

Current Ratio	2.02
Quick Ratio	1.22
Debt / Equity	0.16
Debt / EBITDA	0.94
Debt / FCF	-39.50
Interest Coverage	23.60

Financial Efficiency

Return on equity (ROE) is 11.74% and return on invested capital (ROIC) is 6.86%.

Return on Equity (ROE)	11.74%
Return on Assets (ROA)	5.54%
Return on Invested Capital (ROIC)	6.86%
Return on Capital Employed (ROCE)	10.26%
Revenue Per Employee	507,889
Profits Per Employee	75,371
Employee Count	1,357
Asset Turnover	0.57
Inventory Turnover	1.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.01% in the last 52 weeks. The beta is 0.09, so Antibiotice's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	-6.01%
50-Day Moving Average	2.16
200-Day Moving Average	2.67
Relative Strength Index (RSI)	20.90
Average Volume (20 Days)	227,896

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Antibiotice had revenue of RON 688.70 million and earned 102.20 million in profits. Earnings per share was 0.15.

Revenue	688.70M
Gross Profit	434.28M
Operating Income	107.19M
Pretax Income	103.11M
Net Income	102.20M
EBITDA	152.24M
EBIT	107.19M
Earnings Per Share (EPS)	0.15

Full Income Statement

Balance Sheet

The company has 2.68 million in cash and 143.29 million in debt, giving a net cash position of -140.61 million or -0.21 per share.

Cash & Cash Equivalents	2.68M
Total Debt	143.29M
Net Cash	-140.61M
Net Cash Per Share	-0.21
Equity (Book Value)	894.31M
Book Value Per Share	1.33
Working Capital	239.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 95.15 million and capital expenditures -98.77 million, giving a free cash flow of -3.63 million.

Operating Cash Flow	95.15M
Capital Expenditures	-98.77M
Free Cash Flow	-3.63M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 63.06%, with operating and profit margins of 15.56% and 14.84%.

Gross Margin	63.06%
Operating Margin	15.56%
Pretax Margin	14.97%
Profit Margin	14.84%
EBITDA Margin	22.11%
EBIT Margin	15.56%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 1.14%.

Dividend Per Share	0.02
Dividend Yield	1.14%
Dividend Growth (YoY)	-75.21%
Years of Dividend Growth	2
Payout Ratio	47.13%
Buyback Yield	n/a
Shareholder Yield	1.14%
Earnings Yield	8.46%
FCF Yield	-0.30%

Dividend Details

Stock Splits

The last stock split was on May 13, 2013. It was a forward split with a ratio of 1.1819213313.

Last Split Date	May 13, 2013
Split Type	Forward
Split Ratio	1.1819213313

Scores

Antibiotice has an Altman Z-Score of 4.29.

Altman Z-Score	4.29
Piotroski F-Score	n/a